Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism

Tania Fernandez1, Stephanie Amoroso, Shellyann Sharpe

  • 1Laboratory of Cell Regulation and Carcinogenesis, The National Cancer Institute, The National Institutes of Health, Bethesda, MD 20892, USA.

Insights

Transforming growth factor-beta (TGF-β) can bind to its receptor intracellularly in plasma cell tumors. This binding impacts receptor trafficking but does not appear to activate downstream signaling pathways.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Biology

Background:

  • Transforming growth factor-beta (TGF-β) is a key regulator of cell development and function, acting through autocrine and paracrine pathways.
  • TGF-β is secreted as an inactive latent complex, and its regulation is crucial for pathway activity.
  • Normal cells express both TGF-β isoforms and their receptors, maintaining controlled signaling.

Purpose of the Study:

  • To investigate intracellular TGF-β ligand-receptor interactions within plasma cell tumors (PCTs).
  • To determine if active TGF-β1 binds to intracellular TGF-beta type II receptor (TbetaRII) in PCTs.
  • To elucidate the impact of intracellular TGF-β-TbetaRII binding on receptor trafficking and signaling.

Main Methods:

  • Studied pristane-induced plasma cell tumors (PCTs) to analyze TGF-β signaling.
  • Utilized antisense TGF-β1 mRNA to disrupt TGF-β1 expression and observe TbetaRII localization.
  • Employed retroviral expression of a dominant-negative TbetaRII (dnTbetaRII) to compete for intracellular ligand binding.
  • Analyzed TGF-β receptor-activated Smad2 phosphorylation to assess signaling activation.

Main Results:

  • Demonstrated that active TGF-β1 binds to intracellular TbetaRII in PCTs.
  • Showed that disrupting TGF-β1 expression restores TbetaRII to the cell surface, indicating ligand-induced trafficking impediment.
  • Confirmed that dnTbetaRII competes for intracellular TGF-β1 binding and restores cell surface TbetaRII.
  • Found that the intracellular TGF-β-TbetaRII complex does not appear to activate Smad2-mediated signaling.

Conclusions:

  • Established the first evidence of an intracellular TGF-β-receptor complex formation.
  • Defined a novel mechanism for modulating TGF-β signaling through intracellular interactions.
  • Highlighted a potential regulatory pathway impacting receptor trafficking in cancer cells.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...